A professor and vice chair for clinical research at Stony Brook School of Medicine, Dr. Elliott Bennett-Guerrero also serves as medical director of perioperative quality and patient safety in the Department of Anesthesiology. In his leadership role with the university, Dr. Elliott Bennett-Guerrero focuses a portion of his research on the safety and effectiveness of blood transfusions.
Chronic Kidney Disease Challenges and New SolutionsViewics
A critical population management challenge concerns chronic kidney disease (CKD), which impacts about half of the Medicare population and of diabetics. More than 50% of adults over 30 years of age are likely to develop CKD during their lifetime, and the prevalence of CKD is expected to climb over the next 15 years. Current CKD management is variable and suboptimal, as categorizing the very heterogeneous CKD patient population into risk cohorts for purposes of appropriate treatment is inaccurate. Without accurate risk classification, many patients are over-treated, leading to wasted expenses and adverse events, while others are not identified in time to receive interventions that change the course of the disease.
A new algorithm has been created that predicts patients’ risk of renal failure based on a specific set of laboratory tests combined with patient age and gender. Validated by more than 720,000 patients spanning 30 countries, it can reliably predict a patient’s risk of experiencing renal failure requiring dialysis or transplant. Studies show that a lab-based analytics program that incorporates this algorithm with care protocols, dashboards, and educational patient reports can generate substantial savings and improved outcomes for ACOs and health systems.
Chronic Kidney Disease Challenges and New SolutionsViewics
A critical population management challenge concerns chronic kidney disease (CKD), which impacts about half of the Medicare population and of diabetics. More than 50% of adults over 30 years of age are likely to develop CKD during their lifetime, and the prevalence of CKD is expected to climb over the next 15 years. Current CKD management is variable and suboptimal, as categorizing the very heterogeneous CKD patient population into risk cohorts for purposes of appropriate treatment is inaccurate. Without accurate risk classification, many patients are over-treated, leading to wasted expenses and adverse events, while others are not identified in time to receive interventions that change the course of the disease.
A new algorithm has been created that predicts patients’ risk of renal failure based on a specific set of laboratory tests combined with patient age and gender. Validated by more than 720,000 patients spanning 30 countries, it can reliably predict a patient’s risk of experiencing renal failure requiring dialysis or transplant. Studies show that a lab-based analytics program that incorporates this algorithm with care protocols, dashboards, and educational patient reports can generate substantial savings and improved outcomes for ACOs and health systems.
An experienced anesthesiologist and perioperative specialist, Dr. Elliott Bennett-Guerrero recently accepted a position as professor and vice chair for clinical research and innovation at Stony Brook University School of Medicine. Complementing his professional work, Dr. Elliott Bennett-Guerrero has written several scholarly articles on blood transfusions in cardiac surgery.
Immigration Physicals & Medical Exam Testing in Frisco, Mckinney, TexasHarsithaK1
Get full Immigration medical exam checkups, immigration physicals exam services from the best medical clinic & health center in Frisco, Mckinney, Texas. Best vaccinations and blood tests clinic
Immigration Physicals Medical Exam Testing in Frisco, Mckinney, TexasHarsithaK1
Get full Immigration medical exam checkups, immigration physicals exam services from the best medical clinic & health center in Frisco, Mckinney, Texas. Best vaccinations and blood tests clinic
An accomplished anesthesiologist, Dr. Elliott Bennett-Guerrero serves as both a professor and vice president of the Department of Anesthesiology, as well as medical director for Perioperative Quality and Patient Safety, at Stony Brook Medicine. In April 2020, Dr. Elliott Bennett-Guerrero initiated a clinical study on a potential cure for ill patients who have tested positive for COVID-19.
The rapid increase in mortality rate associated with the spread of the novel coronavirus infection has spurred the urgent need for research-driven therapies. In an effort to address this issue, researchers at Stony Brook Medicine revisited a century-old approach to treating infectious diseases known as convalescent plasma. This involves introducing antibody-rich plasma from a healthy patient (who had recovered from the virus) to a sick patient's blood serum to optimize immune response to the infection.
According to Dr. Elliott Bennett-Guerrero, the lead researcher, an infected patient may gain an immune system benefit enabling recovery from the illness through an antibody-rich plasma transfusion. He also added that the approach is potentially beneficial at the early stages of the disease, when patients are yet to develop sufficient levels of antibodies to fight the infection. This study was approved by the FDA on April 2, 2020.
A graduate of Harvard Medical School, Dr. Elliott Bennett Guerrero is the vice chairman and a professor of Anesthesiology at Stony Brook Medicine. In this capacity, Elliott Bennett Guerrero led a clinical trial for a coronavirus treatment with blood plasma.
In 2020, Stony Brook Medicine conducted research to see if the administration of blood plasma from individuals that have survived an infection with coronavirus -19 (COVID-19) can help patients who are hospitalized with COVID-19 infection . Convalescent plasma contains antibodies to COVID-19 and was theorized to have potential to help people who have not yet mounted an immune response to the virus. The study found that the administration of convalescent plasma increased antibodies to the virus that causes COVID-19 infection, but did not improve patient's survival or other clinical outcomes.
This clinical trial's results were published in Critical Care Medicine, which is the official journal of the Society of Critical Care Medicine (SCCM). The SCCM is the largest organization dedicated to improving the care of critically ill patients. It has members in more than 100 countries. More information about the SCCM can be found at: https://www.sccm.org
A graduate of Harvard Medical School, Elliott Bennett-Guerrero is a professor and vice-chairman of Stony Brook Medicine's department of anesthesiology. Elliott Bennett-Guerrero has conducted several studies related to COVID-19 including the use of convalescent blood plasma. A randomized clinical trial he led was published in the journal Critical Care Medicine: Convalescent Plasma Versus Standard Plasma in Coronavirus Disease 2019 Infected Hospitalized Patients in New York: A Double-Blind Randomized Trial. Critical Care Medicine. 2021 Jul 1;49(7):1015-1025. PMID: 33870923.
Convalescent blood plasma treatment has been used for patients that have the COVID-19 virus, however, studies have not shown it to be beneficial in most hospitalized patients. It involves plasma transfusion from people who have already recovered from the condition. The treatment and therapy is likely to be most beneficial in people that are in the early stage of the condition or who have a weak immune system and cannot mount their own antibody response to the infection.
The therapy can have rare side effects and risks that include allergic reactions . Although it can have risks, there were more than 500,000 people treated in the United States with the therapy and few felt any side effects.
Global Medical Cures™ | Genetic Testing Handbook
DISCLAIMER-
Global Medical Cures™ does not offer any medical advice, diagnosis, treatment or recommendations. Only your healthcare provider/physician can offer you information and recommendations for you to decide about your healthcare choices.
2011; 33 e50–e56WEB PAPERThe ethics of HIV testing an.docxvickeryr87
2011; 33: e50–e56
WEB PAPER
The ethics of HIV testing and disclosure for
healthcare professionals: What do our future
doctors think?
JULIE M. AULTMAN1 & NICOLE J. BORGES2
1Northeastern Ohio Universities College of Medicine, USA, 2Wright State University Boonshoft School of Medicine, USA
Abstract
Aim: This study examined future medical professionals’ attitudes and beliefs regarding mandatory human immunodeficiency virus
(HIV) testing and disclosure.
Method: A total of 54 US medical students were interviewed regarding mandatory testing and disclosure of HIV status for both
patient and health care professional populations. Interviews were qualitatively analyzed using thematic analysis by the first author
and verified by the second author.
Results: Medical students considered a variety of perspectives, even placing themselves in the shoes of their patients or imagining
themselves as a healthcare professional with HIV. Mixed opinions were presented regarding the importance of HIV testing for
students coupled with a fear about school administration regarding HIV positive test results and the outcome of a student’s career.
Third- and fourth-year medical students felt that there should be no obligation to disclose one’s HIV status to patients, colleagues,
or employers. However, most of these students did feel that patients had an obligation to disclose their HIV status to healthcare
professionals.
Conclusion: This study gives medical educators a glimpse into what our future doctors think about HIV testing and disclosure, and
how difficult it is for them to recognize that they can be patients too, as they are conflicted by professional and personal values.
Introduction
The overall aim of this qualitative study is to gain a deeper
understanding of future doctors’ attitudes and beliefs regarding
mandatory human immunodeficiency virus (HIV) testing and
disclosure, and to explore current medical students’ personal
biases and stigmas surrounding HIV testing and disclosure.
Present and future doctors may face the challenges of having
to not only request that patients disclose their HIV status, but
also to decide whether to report one’s own HIV status to
patients, colleagues, and/or employing healthcare institutions.
By examining and identifying some of the beliefs and attitudes
surrounding such dilemmas, we believe this information can
be of help to medical educators as they work with medical
students and their clinical preceptors to resolve many of the
social and ethical problems associated with the stigma of HIV
disclosure, while improving the overall health of individuals
and communities. In addition to the presentation and analysis
of our data, we provide curriculum recommendations for
ethics education for HIV testing and disclosure for medical
students. First, we will provide descriptive background infor-
mation on HIV testing and disclosure.
HIV testing
In the United States, there are several private and public.
Immigration Physicals health care
Immigration medical exam clinics in Frisco are an important component of the immigration process, ensuring that individuals entering a new country are in good health and do not pose a risk to public health. These medical exams aim to identify and address any existing medical conditions, communicable diseases, or potential health risks.
The specific requirements for immigration medical exam clinic in mckinney may vary depending on the destination country's immigration policies and regulations. Generally, individuals seeking immigration are required to undergo a comprehensive medical examination conducted by a designated panel physician or a civil surgeon authorized by the immigration authorities.
The medical examination typically includes the following components:
Medical history: The healthcare provider will review the individual's medical history, including past illnesses, surgeries, and current medications. This information helps in assessing the individual's overall health status.
Physical examination: A thorough physical examination is conducted to assess various aspects of the individual's health, including vital signs (such as blood pressure, heart rate, and temperature), general appearance, and organ systems. This examination may include checking the individual's vision, hearing, and mobility.
Vaccination review: The healthcare provider will review the individual's vaccination records and ensure that they are up to date with the immigration physical exam in frisco requirements of the destination country. If any vaccines are missing, the provider may administer them during the examination.
Tuberculosis (TB) screening: Tuberculosis is a common disease screened during immigration physicals. This may involve a tuberculin skin test (TST) or a blood test (interferon-gamma release assay) to check for TB infection. In some cases, a chest X-ray may be required to further evaluate the individual's respiratory health.
Infectious disease screening: Depending on the destination country's requirements, individuals may be screened for various infectious diseases such as syphilis, HIV, hepatitis B, and hepatitis C. This is typically done through blood tests.
The results of the immigration physical examination are usually documented on a specific form provided by the immigration health exam in mckinney authorities. If the individual is found to have any medical conditions or diseases, further evaluation and treatment may be required before immigration approval.
It's important to note that immigration physicals primarily focus on public health and may not include a comprehensive evaluation of all health conditions. Therefore, individuals are advised to continue their regular healthcare and consult with their primary healthcare providers for ongoing medical needs.
An experienced anesthesiologist and perioperative specialist, Dr. Elliott Bennett-Guerrero recently accepted a position as professor and vice chair for clinical research and innovation at Stony Brook University School of Medicine. Complementing his professional work, Dr. Elliott Bennett-Guerrero has written several scholarly articles on blood transfusions in cardiac surgery.
Immigration Physicals & Medical Exam Testing in Frisco, Mckinney, TexasHarsithaK1
Get full Immigration medical exam checkups, immigration physicals exam services from the best medical clinic & health center in Frisco, Mckinney, Texas. Best vaccinations and blood tests clinic
Immigration Physicals Medical Exam Testing in Frisco, Mckinney, TexasHarsithaK1
Get full Immigration medical exam checkups, immigration physicals exam services from the best medical clinic & health center in Frisco, Mckinney, Texas. Best vaccinations and blood tests clinic
An accomplished anesthesiologist, Dr. Elliott Bennett-Guerrero serves as both a professor and vice president of the Department of Anesthesiology, as well as medical director for Perioperative Quality and Patient Safety, at Stony Brook Medicine. In April 2020, Dr. Elliott Bennett-Guerrero initiated a clinical study on a potential cure for ill patients who have tested positive for COVID-19.
The rapid increase in mortality rate associated with the spread of the novel coronavirus infection has spurred the urgent need for research-driven therapies. In an effort to address this issue, researchers at Stony Brook Medicine revisited a century-old approach to treating infectious diseases known as convalescent plasma. This involves introducing antibody-rich plasma from a healthy patient (who had recovered from the virus) to a sick patient's blood serum to optimize immune response to the infection.
According to Dr. Elliott Bennett-Guerrero, the lead researcher, an infected patient may gain an immune system benefit enabling recovery from the illness through an antibody-rich plasma transfusion. He also added that the approach is potentially beneficial at the early stages of the disease, when patients are yet to develop sufficient levels of antibodies to fight the infection. This study was approved by the FDA on April 2, 2020.
A graduate of Harvard Medical School, Dr. Elliott Bennett Guerrero is the vice chairman and a professor of Anesthesiology at Stony Brook Medicine. In this capacity, Elliott Bennett Guerrero led a clinical trial for a coronavirus treatment with blood plasma.
In 2020, Stony Brook Medicine conducted research to see if the administration of blood plasma from individuals that have survived an infection with coronavirus -19 (COVID-19) can help patients who are hospitalized with COVID-19 infection . Convalescent plasma contains antibodies to COVID-19 and was theorized to have potential to help people who have not yet mounted an immune response to the virus. The study found that the administration of convalescent plasma increased antibodies to the virus that causes COVID-19 infection, but did not improve patient's survival or other clinical outcomes.
This clinical trial's results were published in Critical Care Medicine, which is the official journal of the Society of Critical Care Medicine (SCCM). The SCCM is the largest organization dedicated to improving the care of critically ill patients. It has members in more than 100 countries. More information about the SCCM can be found at: https://www.sccm.org
A graduate of Harvard Medical School, Elliott Bennett-Guerrero is a professor and vice-chairman of Stony Brook Medicine's department of anesthesiology. Elliott Bennett-Guerrero has conducted several studies related to COVID-19 including the use of convalescent blood plasma. A randomized clinical trial he led was published in the journal Critical Care Medicine: Convalescent Plasma Versus Standard Plasma in Coronavirus Disease 2019 Infected Hospitalized Patients in New York: A Double-Blind Randomized Trial. Critical Care Medicine. 2021 Jul 1;49(7):1015-1025. PMID: 33870923.
Convalescent blood plasma treatment has been used for patients that have the COVID-19 virus, however, studies have not shown it to be beneficial in most hospitalized patients. It involves plasma transfusion from people who have already recovered from the condition. The treatment and therapy is likely to be most beneficial in people that are in the early stage of the condition or who have a weak immune system and cannot mount their own antibody response to the infection.
The therapy can have rare side effects and risks that include allergic reactions . Although it can have risks, there were more than 500,000 people treated in the United States with the therapy and few felt any side effects.
Global Medical Cures™ | Genetic Testing Handbook
DISCLAIMER-
Global Medical Cures™ does not offer any medical advice, diagnosis, treatment or recommendations. Only your healthcare provider/physician can offer you information and recommendations for you to decide about your healthcare choices.
2011; 33 e50–e56WEB PAPERThe ethics of HIV testing an.docxvickeryr87
2011; 33: e50–e56
WEB PAPER
The ethics of HIV testing and disclosure for
healthcare professionals: What do our future
doctors think?
JULIE M. AULTMAN1 & NICOLE J. BORGES2
1Northeastern Ohio Universities College of Medicine, USA, 2Wright State University Boonshoft School of Medicine, USA
Abstract
Aim: This study examined future medical professionals’ attitudes and beliefs regarding mandatory human immunodeficiency virus
(HIV) testing and disclosure.
Method: A total of 54 US medical students were interviewed regarding mandatory testing and disclosure of HIV status for both
patient and health care professional populations. Interviews were qualitatively analyzed using thematic analysis by the first author
and verified by the second author.
Results: Medical students considered a variety of perspectives, even placing themselves in the shoes of their patients or imagining
themselves as a healthcare professional with HIV. Mixed opinions were presented regarding the importance of HIV testing for
students coupled with a fear about school administration regarding HIV positive test results and the outcome of a student’s career.
Third- and fourth-year medical students felt that there should be no obligation to disclose one’s HIV status to patients, colleagues,
or employers. However, most of these students did feel that patients had an obligation to disclose their HIV status to healthcare
professionals.
Conclusion: This study gives medical educators a glimpse into what our future doctors think about HIV testing and disclosure, and
how difficult it is for them to recognize that they can be patients too, as they are conflicted by professional and personal values.
Introduction
The overall aim of this qualitative study is to gain a deeper
understanding of future doctors’ attitudes and beliefs regarding
mandatory human immunodeficiency virus (HIV) testing and
disclosure, and to explore current medical students’ personal
biases and stigmas surrounding HIV testing and disclosure.
Present and future doctors may face the challenges of having
to not only request that patients disclose their HIV status, but
also to decide whether to report one’s own HIV status to
patients, colleagues, and/or employing healthcare institutions.
By examining and identifying some of the beliefs and attitudes
surrounding such dilemmas, we believe this information can
be of help to medical educators as they work with medical
students and their clinical preceptors to resolve many of the
social and ethical problems associated with the stigma of HIV
disclosure, while improving the overall health of individuals
and communities. In addition to the presentation and analysis
of our data, we provide curriculum recommendations for
ethics education for HIV testing and disclosure for medical
students. First, we will provide descriptive background infor-
mation on HIV testing and disclosure.
HIV testing
In the United States, there are several private and public.
Immigration Physicals health care
Immigration medical exam clinics in Frisco are an important component of the immigration process, ensuring that individuals entering a new country are in good health and do not pose a risk to public health. These medical exams aim to identify and address any existing medical conditions, communicable diseases, or potential health risks.
The specific requirements for immigration medical exam clinic in mckinney may vary depending on the destination country's immigration policies and regulations. Generally, individuals seeking immigration are required to undergo a comprehensive medical examination conducted by a designated panel physician or a civil surgeon authorized by the immigration authorities.
The medical examination typically includes the following components:
Medical history: The healthcare provider will review the individual's medical history, including past illnesses, surgeries, and current medications. This information helps in assessing the individual's overall health status.
Physical examination: A thorough physical examination is conducted to assess various aspects of the individual's health, including vital signs (such as blood pressure, heart rate, and temperature), general appearance, and organ systems. This examination may include checking the individual's vision, hearing, and mobility.
Vaccination review: The healthcare provider will review the individual's vaccination records and ensure that they are up to date with the immigration physical exam in frisco requirements of the destination country. If any vaccines are missing, the provider may administer them during the examination.
Tuberculosis (TB) screening: Tuberculosis is a common disease screened during immigration physicals. This may involve a tuberculin skin test (TST) or a blood test (interferon-gamma release assay) to check for TB infection. In some cases, a chest X-ray may be required to further evaluate the individual's respiratory health.
Infectious disease screening: Depending on the destination country's requirements, individuals may be screened for various infectious diseases such as syphilis, HIV, hepatitis B, and hepatitis C. This is typically done through blood tests.
The results of the immigration physical examination are usually documented on a specific form provided by the immigration health exam in mckinney authorities. If the individual is found to have any medical conditions or diseases, further evaluation and treatment may be required before immigration approval.
It's important to note that immigration physicals primarily focus on public health and may not include a comprehensive evaluation of all health conditions. Therefore, individuals are advised to continue their regular healthcare and consult with their primary healthcare providers for ongoing medical needs.
In 2014, US healthcare spending exceeded $3.0 trillion with nearly 1/3 spent on hospitalizations. Informed by real-world data from an Electronic Health Record (EHR) database of clinical and administrative records spanning 273 million encounters for 60 million patients in 600+ hospitals across the US, Boston Strategic Partners (BSP) Clinical Insights report, Hospital Treated Sepsis, estimates 30% of all hospital discharges involve treatment of infectious organisms.
Sepsis is responsible for an estimated 12% of all hospital stays. At an average cost of $15,500 per occurrence, we estimate that hospitalizations for severe infections account for $212 billion in annual spending or 7% of total healthcare expenditure. In this report, we conduct an in-depth analysis of sepsis patient characteristics, medication management, costs, and laboratory testing.
The Hospital-Treated Sepsis Report is available at www.bostonsp.com/reports
Gram-positive bacteria are the likely causative agents of most sepsis infections. Physicians treat the vast majority of these infections with vancomycin, piperacillin-tazobactam, levofloxacin, and ceftriaxone. From 2010-2015, drug-resistant organisms caused an astonishing 40% of bacterial sepsis infections. After confirmatory diagnosis, over half of sepsis patients undergo a change in antibiotic therapy.
This report provides quantitative, objective data captured by hospitals contributing to Cerner Health Facts. This data provides real-world patient encounters and reflects real physician decisions and encounter characteristics (e.g. patient response to therapy and outcomes) in key areas, such as antibiotic resistant pathogens and antimicrobial stewardship.
Medical tourism, the practice of traveling to another country to receive medical treatment, has had a significant impact on the kidney transplant market. In countries with lengthy waiting lists and organ shortages, patients often seek alternatives abroad where kidneys are more readily available. This trend has given rise to specialized medical tourism destinations, where patients can access quality healthcare and undergo kidney transplants with shorter waiting times.
Similar to Principles of Blood Transfusion Safety (20)
A New York resident, Dr. Elliott Bennett-Guerrero has a doctor of medicine degree and is currently the professor and vice chairman in the Department of Anesthesiology at Stony Brook Medicine. Dr. Elliott Bennett-Guerrero led a clinical trial in which Stony Brook tested a new coronavirus treatment.
Convalescent blood plasma therapy was a proposed treatment for coronavirus patients. The therapy consists of transfusing plasma from a person that has recovered from an infection with coronavirus. The therapy was mostly used in patients that were hospitalized or those who recently developed the condition for a few days. Multiple studies showed that the therapy could increase desirable antibodies to COVID, but in general this was not very helpful in terms of likelihood of recovery from the infection or reduction in symptoms.
Dr. Elliott Bennett-Guerrero is a professor of anesthesiology and vice-chair for clinical research at Stony Brook Medicine. Some of Dr. Elliott Bennett-Guerrero's research work focuses on treatment methods for the coronavirus disease, and on the safety of blood transfusions.
Blood transfusions are generally safe; however, there is still a possibility of complications. One of such complications is the acute immune hemolytic reaction, in which a person's immune system resists the transfusion and produces antibodies that attack the blood cells. The hemolytic reaction occurs when the donor's blood cells are not compatible with those of the recipient patient. When the immune system fights back against the transfusion, it releases a substance that can damage and harm the kidneys.
Acute immune hemolytic reactions may cause symptoms such as fever, bloody urine, or even cause a person to faint. The symptoms may appear during the procedure, or after it ends, and in some cases, a few days after. In extreme cases, the reaction can result in significant damage to a person's internal organs, including acute kidney failure. However, the reaction may pass without major damage to the body system. Doctors treat mild hemolytic reactions with pain relievers such as acetaminophen and in some cases with medications that can prevent kidney failure. Complications like this can be avoided by carefully screening all blood before transfusion.
A respected clinician, dual board-certified in anesthesiology and critical care medicine, Elliott Bennett-Guerrero, MD, is a professor of anesthesiology at Stony Brook Medicine in New York. In addition, he also serves as vice chairman for clinical research and innovation in the department of anesthesiology. At Stony Brook, Dr. Elliott Bennett-Guerrero led a significant COVID-19-related randomized trial of convalescent plasma in COVID-19-infected hospitalized patients.
In 2021, over three peer-reviewed publications suggested that convalescent plasma could help people recover from COVID-19 infection better, while the viral strain of concern was SARS-CoV- 2. The majority of these publications did not compare the efficacy of convalescent plasma in disease treatment with standard plasma. To address this concern and solidify scientific evidence, a group of researchers in New York conducted a double-bind randomized control trial that compared COVID-19 patients who were recipients of convalescent plasma with another group of COVID-19 patients who received standard plasma. As mentioned in the study category, the patients were selected randomly.
Convalescent plasma is different from standard plasma because it is collected from people who have recovered from the virus. These people have a high level of anti-viral proteins called anti-COVID antibodies. Antibodies fight diseases by hampering viral replication and mitigating the rate of cellular infection by viruses. Plasma is a blood component free of red blood cells and platelets.
The researchers saw a significant increase in antibody levels in those who received convalescent plasma compared to those given regular standard plasma. The study, however, did not observe a significant improvement in clinical outcomes, although it may have been underpowered to show small improvements attributable to the plasma.
An experienced and active ICU physician, Elliott Bennett-Guerrero is also medical director for perioperative quality and patient safety at Stony Brook Medicine. Elliott Bennett-Guerrero has conducted studies in search of new coronavirus treatments.
Stony Brook Medicine conducted a study on whether convalescent blood plasma from people with a prior Covid-19 infection can be used to help others recover from it. The clinical trial was published in Critical Care Medicine, which is the official journal of the Society of Critical Care Medicine. In the trial, Stony Brook used a test to verify whether a person who had Covid-19 had a sufficient number of IgG and IgM antibodies for use in treatment. This test analyzes a drop of blood from a fingertip and offers results in approximately 15 minutes. The study then randomized hospitalized patients with COVID-19 infection to receive either 2 bags of this "convalescent" plasma or 2 bags of standard plasma (not high in antibodies to COVID-19. The study showed that this treatment increased antibodies to COVID-19 but it did not demonstrate an improvement in patient outcome.
Based in Stony Brook, New York, Dr. Elliott Bennett-Guerrero leads the Department of Anesthesiology at Stony Brook Medicine as the vice chair of clinical research and innovation. Concurrent to this role, Dr. Elliott Bennett-Guerrero helps educate the new generation of medical professionals as a professor of anesthesiology.
Despite the routine use of prophylactic systemic antibiotics, surgical-site infection continues to be associated with significant morbidity and cost after colorectal sur- gery. The gentamicin–collagen sponge, an implantable topical antibiotic agent, is approved for surgical implantation in 54 countries. Since 1985, more than 1 million patients have been treated with the sponges.
Some observational studies have reported that transfusion of red-cell units that have been stored for more than 2 to 3 weeks is associated with serious, even fatal, adverse events. Patients undergoingcardiac surgery may be especially vulnerable to the adverse effects of transfusion.
Perioperativebloodtransfusionsarecostlyandhavesafetyconcerns.Asa result, there have been multiple initiatives to reduce transfusion use. However, the degree to which perioperative transfusion rates vary among hospitals is unknown.
Objective Toassesshospital-levelvariationinuseofallogeneicredbloodcell(RBC), fresh-frozen plasma, and platelet transfusions in patients undergoing coronary artery bypass graft (CABG) surgery.
Despitetheroutineuseofprophylacticsystemicantibiotics,sternalwoundin- fection still occurs in 5% or more of cardiac surgical patients and is associated with signifi- cant excess morbidity, mortality, and cost. The gentamicin-collagen sponge, a surgically implantable topical antibiotic, is currently approved in 54 countries. A large, 2-center, ran- domized trial in Sweden reported in 2005 that the sponge reduced surgical site infection by 50% in cardiac patients.
A former participant in PBS’ Doctors’ Diaries, Dr. Elliott Bennett-Guerrero serves as the director of Perioperative Clinical Research at the Duke Clinical Research Institute. Dr. Elliott Bennett-Guerrero concurrently hosts lectures as a professor of anesthesiology at the Duke University School of Medicine.
For more than 10 years, Elliott Bennett-Guerrero, MD, has lectured on anesthesiology and directed perioperative research at Duke University. In addition to these responsibilities, Elliott Bennett-Guerrero has overseen several clinical studies as a principal investigator.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
2. Introduction
A professor and vice chair for clinical research at
Stony Brook School of Medicine, Dr. Elliott
Bennett-Guerrero also serves as medical director
of perioperative quality and patient safety in the
Department of Anesthesiology. In his leadership
role with the university, Dr. Elliott Bennett-
Guerrero focuses a portion of his research on the
safety and effectiveness of blood transfusions.
When it comes to blood-transfusion safety,
positive patient identification represents one of the
most important safety protocols. At all stages of
the process, healthcare providers should ask for
the patient’s full name and date of birth.
3. Blood Transfusion Safety
Furthermore, all paperwork involving the patient
must have all information identical, complete with
the patient’s unique identification number.
All prospective donors must be asked a
comprehensive set of screening questions to
determine risk factors for blood transfusion.
Recent travel to high-risk countries or a history of
intravenous drug use are some of the factors that
may exclude a prospective donor. After the blood
is collected, it must be tested in the laboratory for
blood-borne pathogens, such as HIV, hepatitis B
and C, bacterial contamination, and more.